These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7695476)

  • 1. New NO-donors with antithrombotic and vasodilating activities, XI: 2-Nitrosiminobenzimidazoles.
    Rehse K; Birkhofer G
    Arch Pharm (Weinheim); 1995 Jan; 328(1):77-80. PubMed ID: 7695476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New NO-donors with antithrombotic and vasodilating activities, VIII: Benzothiazole-2(3H)-nitrosimines.
    Rehse K; Ciborski T; Lüdtke E
    Arch Pharm (Weinheim); 1994 Dec; 327(12):771-7. PubMed ID: 7872854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New NO-donors with antithrombotic activities and vasodilating activities, III: 3,4-disubstituted N-nitroso-5-sydnone imines.
    Rehse K; Schleifer KJ
    Arch Pharm (Weinheim); 1993 Dec; 326(12):929-39. PubMed ID: 8122963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New NO-donors with antithrombotic and vasodilating activities, Part 21. Pseudonitrosites and other azodioxides with vicinal electron acceptors.
    Rehse K; Herpel M
    Arch Pharm (Weinheim); 1998 Mar; 331(3):111-7. PubMed ID: 9557137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New NO-donors with antithrombotic and vasodilating activities, Part 20. Azodioxides activated by electron acceptors in geminal or vicinal position.
    Rehse K; Herpel M
    Arch Pharm (Weinheim); 1998 Mar; 331(3):104-10. PubMed ID: 9557136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New NO-donors with antithrombotic and vasodilating activities, Part 19. Pseudonitroles and their dimeric azodioxides.
    Rehse K; Herpel M
    Arch Pharm (Weinheim); 1998 Feb; 331(2):79-84. PubMed ID: 9525092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New NO-donors with antithrombotic and vasodilating activities, XII: Mesoionic oxatriazoles and related noncyclic nitrosohydrazine derivatives.
    Rehse K; König P
    Arch Pharm (Weinheim); 1995 Feb; 328(2):137-42. PubMed ID: 7726739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New NO donors with antithrombotic and vasodilating activities, Part 24. Hydrazine derivatives.
    Rehse K; Shahrouri T
    Arch Pharm (Weinheim); 1998 Oct; 331(10):308-12. PubMed ID: 9844577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New NO-donors with antithrombotic and vasodilating activities, IX: Thiadiazole nitrosimines.
    Rehse K; Lüdtke E
    Arch Pharm (Weinheim); 1995 Jan; 328(1):17-20. PubMed ID: 7695468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New NO-donors with antithrombotic and vasodilating activities, I: 3-Arylalkyl-N-nitroso-5-sydnone imines.
    Rehse K; Kämpfe M; Schleifer KJ
    Arch Pharm (Weinheim); 1993 Aug; 326(8):483-7. PubMed ID: 8215847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New NO-donors with antithrombotic and vasodilating activities, Part 14. 1,3,4-Triazol-1-oles.
    Rehse K; Piechocki D; Schober M; Scheffler H; Reitner N; Unsöld E
    Arch Pharm (Weinheim); 1996 Nov; 329(11):511-3. PubMed ID: 8997901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New NO-donors with antithrombotic and vasodilating activities, V: Oligonitroso sydnone imines.
    Rehse K; Schleifer KJ; Martens A; Kämpfe M
    Arch Pharm (Weinheim); 1994 Jun; 327(6):393-7. PubMed ID: 8048846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New NO-donors with antithrombotic and vasodilating activities, II: 3-alkyl-N-nitroso-5-sydnone imines.
    Rehse K; Schleifer KJ; Ciborski T; Bohn H
    Arch Pharm (Weinheim); 1993 Oct; 326(10):791-7. PubMed ID: 8267514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New NO-donors with antithrombotic and vasodilating activities, VI: thiazole-2-nitrosimines.
    Rehse K; Lüdtke E
    Arch Pharm (Weinheim); 1994 Sep; 327(9):581-9. PubMed ID: 7979924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New NO donors with antithrombotic and vasodilating activities, Part 27. Azide oximes and 1-hydroxytetrazoles.
    Rehse K; Brehme F
    Arch Pharm (Weinheim); 2000 Jun; 333(6):157-61. PubMed ID: 10909186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New NO-donors with antithrombotic and vasodilating activities, Part 16. 3-Amino-1,2,4-oxadiazol-5-ones as prodrugs for hydroxyguanidines.
    Rehse K; Bade S
    Arch Pharm (Weinheim); 1996 Dec; 329(12):535-40. PubMed ID: 9038421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New NO donors with antithrombotic and vasodilating activities, Part 28. N-(1-cyanoalkyl)-N-hydroxyureas.
    Camehn R; Rehse K
    Arch Pharm (Weinheim); 2000 Jan; 333(1):27-31. PubMed ID: 10675986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New NO-donors with antithrombotic and vasodilating activities, part 15 nitrolic acids.
    Rehse K; Herpel M; Piechocki D
    Arch Pharm (Weinheim); 1996 Feb; 329(2):83-6. PubMed ID: 8851471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NO donors with antithrombotic and vasodilating activities, Part 23. Organic azides.
    Satyanarayana K; Rehse K
    Arch Pharm (Weinheim); 1998 Jun; 331(6):207-10. PubMed ID: 9713253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
    Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
    Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.